MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Recs

0
Player Avatar 1badbeerad (33.99) Submitted: 12/31/2012 10:13:57 PM : Outperform Start Price: $0.00 MNKD Score: 0

Jan effect

Featured Broker Partners


Advertisement